Association of Aurora-A (STK15) kinase polymorphisms with clinical outcome of esophageal cancer treated with preoperative chemoradiation.
about
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approachAurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior.Investigational Aurora A kinase inhibitor alisertib (MLN8237) as an enteric-coated tablet formulation in non-hematologic malignancies: phase 1 dose-escalation study.Aurora-A V57I (rs1047972) polymorphism and cancer susceptibility: a meta-analysis involving 27,269 subjects.A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.Association between XRCC1 and ERCC1 single-nucleotide polymorphisms and the efficacy of concurrent radiochemotherapy in patients with esophageal squamous cell carcinoma.Germline and somatic genetic predictors of pathological response in neoadjuvant settings of rectal and esophageal cancers: systematic review and meta-analysis.Predictive role of host constitutive variants in neoadjuvant therapy of esophageal cancer.Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy.The response of head and neck squamous cell carcinoma to cetuximab treatment depends on Aurora kinase A polymorphism.A single nucleotide polymorphism in codon F31I and V57I of the AURKA gene in invasive ductal breast carcinoma in Middle East.Aurora A Functional Single Nucleotide Polymorphism (SNP) Correlates With Clinical Outcome in Patients With Advanced Solid Tumors Treated With Alisertib, an Investigational Aurora A Kinase Inhibitor.AURKA is a predictor of chemotherapy response and prognosis for patients with advanced oral squamous cell carcinoma.Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer.Polymorphisms in and are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy
P2860
Q26862365-40B15AC9-662D-44AE-86B3-E4657D7785D4Q33688594-BB78B917-084B-4EB9-8A5D-06FDE0E83C55Q34498390-78A9735B-A5C0-48F1-959C-879672F84661Q35111979-3F900F68-3B8C-402D-852D-F7AFB13A1FF9Q35218636-40CCC92B-1D16-45A6-B141-25787E8BCA9FQ37701220-9E71AC2B-CE4A-4DF9-85E1-C52A5072AC59Q38539917-2B176D09-3D54-44D9-85C7-09C86F7D5961Q38834922-E10B4A0B-A8D9-4033-B0AE-84CA26921136Q38894287-D17475C3-2E5F-429D-9EB2-88D7E76A2BCAQ38979464-A89920A7-60AE-4E16-97A9-E2442A0001B0Q42360766-82AF877F-30C6-4687-A762-1E07B22B272CQ47104548-1DC7D8D0-EBD4-4345-B1A2-876DF23BDC99Q52979603-3E3AAB5B-D995-4B5B-BAB8-A202DF827E53Q54478536-0332AE95-31FF-46FA-AB3D-A1A5DC8BF1C6Q57071024-06B22EAE-26A9-4CCD-966B-43C95E2E048A
P2860
Association of Aurora-A (STK15) kinase polymorphisms with clinical outcome of esophageal cancer treated with preoperative chemoradiation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 December 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association of Aurora-A (STK15 ...... h preoperative chemoradiation.
@en
Association of Aurora-A
@nl
type
label
Association of Aurora-A (STK15 ...... h preoperative chemoradiation.
@en
Association of Aurora-A
@nl
prefLabel
Association of Aurora-A (STK15 ...... h preoperative chemoradiation.
@en
Association of Aurora-A
@nl
P2093
P2860
P356
P1433
P1476
Association of Aurora-A (STK15 ...... th preoperative chemoradiation
@en
P2093
Jaffer A Ajani
Julie G Izzo
Maosheng Hung
P2860
P304
P356
10.1002/CNCR.26581
P407
P577
2011-12-27T00:00:00Z